Weight loss and diabetes drugs linked to hair loss, say researchers

US research based on study of 50,000 people
Semaglutide (GLP-1) weight-loss and diabetes drugs like Wegovy and Mounjaro have been linked to an increased risk of hair loss.

Semaglutide (GLP-1) weight-loss and diabetes drugs like Wegovy and Mounjaro have been linked to an increased risk of hair loss.

Weight loss and diabetes drugs such as Mounjaro, Ozempic, and Wegovy are linked to an increased risk of hair loss, researchers say.

People on GLP-1 agonist drugs have been reporting hair loss to regulators, but a new study on around 50,000 people appears to firm up the link.

You have reached your article limit. Already a subscriber? Sign in

Save €40 on an Annual Subscription.​

Continue reading within unlimited digital access and exclusive subscriber benefits.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited